Compass Therapeutics, Inc. (CMPX)
6.175
-0.22
(-3.36%)
USD |
NASDAQ |
Feb 20, 16:00
6.175
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Total Assets (Quarterly) : 231.26M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Arcutis Biotherapeutics, Inc. | 370.98M |
| ImmunityBio, Inc. | 518.99M |
| Biohaven Ltd. | 409.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.65M |
| Shareholders Equity (Quarterly) | 209.61M |
| Debt to Equity Ratio | 0.0471 |
| Current Ratio | 17.82 |
| Net Debt Paydown Yield | -0.28% |